10. Endoscopic
Retrograde
Cholangio-
pancreatography
INTRODUCTION
PATIENT PROFILE
THE PROCEDURE
THE ENDOSCOPIST
COMPLICATIONS AND DEATH
RECOMMENDATIONS
CHAPTER REFERENCES
n = number of cases where information was provided

 

PATIENT PROFILE

Key point
77% of patients undergoing an ERCP had an ASA status of 3 or poorer.

Of all patients having an ERCP 82% (194/237) were aged 70 years or older (Figure 14) and 49% were male.

Figure 14. Age profile of patients undergoing ERCP

Table 38. ASA Status
ASA Status
Total
(%)
1
10
(5)
2
41
(18)
3
96
(43)
4
61
(27)
5
16
(7)
Sub-total
224
Not answered
13
(6)
Total
237

Of all patients having an ERCP 77% (173/224) were graded ASA3 or poorer (Table 38). Interestingly 16 were graded 5, but no specific details were available to the advisors to enable them to assess whether a therapeutic ERCP was appropriate.

Considering the data in Table 38, it is not surprising that patients had the co-morbid conditions as listed in Table 39.

Table 39. Comorbidities for patients undergoing ERCP (answers may be multiple)
System
Total
n = 227
Respiratory
48
Cardiac
90
Neurological
42
Hepatic
114
Renal
42
Total
336
None
27
Not answered
10

From the data available 65% (153/234) of ERCPs were 'expected' procedures (Table 40).
The advisors thought that approximately one third of patients having an urgent/emergency ERCP was appropriate, and that in their experience the commonest causes were biliary sepsis especially from an obstructed common bile duct, bile leaks e.g. post laparoscopic cholecystectomy and gall stone related pancreatitis.

Table 40. Urgency of procedure for ERCP
Urgency of procedure
Total
(%)
Elective/scheduled
153
(65)
Urgent
74
(32)
Emergency
7
(3)
Sub-total
234
Not answered
3
(1)
Total
237

In 69% (155/224) of cases, death within 30 days of the procedure was thought to be a definite risk or expected (Table 41). This reflects that in these patients ERCP was often palliative where the patient had a malignant disease. Overall the patient profile indicates
that mostly these were sick patients of advanced age. Of interest is the advisors view that 68% (162/237) of therapeutic ERCPs were futile, with 90% (146/162) of these patients having an ASA status of 3 or more. The advisors were concerned that patients with
hepatic metastases and no biliary obstruction were having therapeutic ERCPs.

Table 41. Anticipated risk of death for ERCP
Anticipated Risk of Death
Total
(%)
Not expected
20
(9)
Small but significant
49
(22)
Definite risk
129
(58)
Expected
26
(12)
Sub-total
224
Not answered
13
(6)
Total
237

(back to top)